Procter & Gamble (PG) Rule 144 Notice — 582 Shares Proposed Sale
Rhea-AI Filing Summary
Form 144 notice for Procter & Gamble (PG) shows a proposed sale of 582 shares of common stock through Morgan Stanley Smith Barney on the NYSE with an approximate sale date of 10/02/2025 and an aggregate market value of $88,525.11. The securities were acquired as a Restricted Stock Unit award on 10/03/2022 from The Procter & Gamble Company, with 1,901 shares recorded as acquired. The filer previously sold 606 shares on 08/19/2025 for gross proceeds of $95,307.92. The filer affirms no undisclosed material adverse information about the issuer.
Positive
- Disclosure compliance: The filer submitted a Rule 144 notice specifying broker, dates, and values, supporting regulatory transparency
- Seller attestation: The filer affirms they are not aware of undisclosed material adverse information
Negative
- Insider selling: The person proposes to sell 582 shares and sold 606 shares recently, which may be viewed negatively by some investors
Insights
TL;DR: Routine insider Rule 144 sale filing disclosing proposed sale of 582 shares; prior recent sale of 606 shares noted.
This Form 144 is a standard disclosure under Rule 144 indicating an intent to sell restricted shares previously received as RSUs. The filing lists the broker, the approximate sale date, and the aggregate market value, which allows market participants to see near-term potential selling pressure from this account. Transaction sizes (582 and a recent 606-sale) are small relative to the issuer's reported outstanding shares (2,342,371,488), suggesting limited market impact based on disclosed quantities alone.
TL;DR: Disclosure meets Rule 144 requirements and includes the seller's representation about material nonpublic information.
The notice includes the required representation that the seller is not aware of undisclosed material adverse information, and it documents acquisition as RSUs from the issuer. From a governance perspective, timely filing of Form 144 and inclusion of prior recent sales (08/19/2025) supports transparency around insider transactions. The filing does not contain additional governance actions or changes in insider status.